Cargando…

Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status

AIMS: To evaluate the effect of iron deficiency (ID) and/or anaemia on health-related quality of life (HRQoL) in patients with chronic heart failure (CHF). METHODS AND RESULTS: We undertook a post-hoc analysis of a cohort of CHF patients in a single-centre study evaluating cognitive function. At rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Comín-Colet, Josep, Enjuanes, Cristina, González, Gina, Torrens, Ainhoa, Cladellas, Mercè, Meroño, Oona, Ribas, Nuria, Ruiz, Sonia, Gómez, Miquel, Verdú, José Maria, Bruguera, Jordi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2013
Materias:	Co-Morbidity
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782146/ https://www.ncbi.nlm.nih.gov/pubmed/23703106 http://dx.doi.org/10.1093/eurjhf/hft083

Ejemplares similares

Why is Iron Deficiency Recognised as an Important Comorbidity in Heart Failure?
por: Ebner, Nicole, et al.
Publicado: (2019)

Heart failure and dementia: survival in relation to types of heart failure and different dementia disorders
por: Cermakova, Pavla, et al.
Publicado: (2015)

Patients with systemic lupus erythematosus and haematological malignancy at a tertiary care centre: timing, histopathology and therapy
por: Knight, Jason S, et al.
Publicado: (2014)

Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort
por: Urowitz, M B, et al.
Publicado: (2016)

ECG non-specific ST-T and QTc abnormalities in patients with systemic lupus erythematosus compared with rheumatoid arthritis
por: Geraldino-Pardilla, Laura, et al.
Publicado: (2016)

Cardiovascular risk profiles in a lupus cohort: what do different calculators tell us?
por: Boulos, Daniel, et al.
Publicado: (2017)

Myocarditis in systemic lupus erythematosus diagnosed by (18)F-fluorodeoxyglucose positron emission tomography
por: Perel-Winkler, Alexandra, et al.
Publicado: (2018)

Heart Failure and Problems with Frailty Syndrome: Why it is Time to Care About Frailty Syndrome in Heart Failure
por: Uchmanowicz, Izabella, et al.
Publicado: (2019)

Treatment of Heart Failure with Sodium-Glucose Cotransporter 2 Inhibitors and Other Anti-diabetic Drugs
por: Zelniker, Thomas A, et al.
Publicado: (2019)

Subclinical Left Ventricular Dysfunction During Chemotherapy
por: Nicol, Martin, et al.
Publicado: (2019)

Epicardial fat in heart failure patients with mid‐range and preserved ejection fraction
por: van Woerden, Gijs, et al.
Publicado: (2018)

Association of lipoprotein subfractions and glycoprotein acetylation with coronary plaque burden in SLE
por: Purmalek, Monica M, et al.
Publicado: (2019)

Antibodies to Chlamydia trachomatis and reproductive health issues in women with SLE: a case–control study
por: Santos, Alba, et al.
Publicado: (2018)

Bidirectional Relationship Between Cancer and Heart Failure: Old and New Issues in Cardio-oncology
por: Bertero, Edoardo, et al.
Publicado: (2019)

Heart Failure and Cancer: Mechanisms of Old and New Cardiotoxic Drugs in Cancer Patients
por: Cuomo, Alessandra, et al.
Publicado: (2019)

Diet, the Gut Microbiome and Heart Failure
por: Harikrishnan, Sivadasanpillai
Publicado: (2019)

Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials
por: Spitzer, Ernest, et al.
Publicado: (2019)

High-risk coronary plaque in SLE: low-attenuation non-calcified coronary plaque and positive remodelling index
por: Stojan, George, et al.
Publicado: (2020)

Atherosclerosis in SLE: a potential role for serum parathormone levels
por: Giannelou, Mayra, et al.
Publicado: (2020)

Similar progression of carotid intima–media thickness in 7-year surveillance of patients with mild SLE and controls, but this progression is still promoted by dyslipidaemia, lower HDL levels, hypertension, history of lupus nephritis and a higher prednisolone usage in patients
por: Ajeganova, Sofia, et al.
Publicado: (2020)

Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction
por: Shen, Li, et al.
Publicado: (2019)

Autoantibody clustering of lupus-associated pulmonary hypertension
por: Mizus, Marisa, et al.
Publicado: (2019)

Sodium–Glucose Cotransporter-2 Inhibitors and Heart Failure Prevention in Type 2 Diabetes
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2019)

Associations of metabolic syndrome in SLE
por: Apostolopoulos, Diane, et al.
Publicado: (2020)

Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case–control study over 10 years
por: Ajeganova, Sofia, et al.
Publicado: (2021)

Intracellular homocysteine metabolites in SLE: plasma S-adenosylhomocysteine correlates with coronary plaque burden
por: Stojan, George, et al.
Publicado: (2021)

Vaginal microbiota affects urinary tract infection risk in women with systemic lupus erythematosus: a pilot cross-sectional study from Thailand
por: Rotjanapan, Porpon, et al.
Publicado: (2021)

Analysis of prognostic factors in diffuse large B-cell lymphoma associated with rheumatic diseases
por: Gorodetskiy, Vadim, et al.
Publicado: (2021)

Red blood cell-derived phosphatidylserine positive extracellular vesicles are associated with past thrombotic events in patients with systemic erythematous lupus
por: Hasse, Stephan, et al.
Publicado: (2022)

Risk factors for changes in carotid intima media thickness and plaque over 5 years in women with systemic lupus erythematosus
por: Lertratanakul, Apinya, et al.
Publicado: (2021)

Cardiovascular complications of systemic lupus erythematosus: impact of risk factors and therapeutic efficacy—a tertiary centre experience in an Appalachian state
por: McVeigh, Elise Danielle, et al.
Publicado: (2021)

Myocardial infarctions, subtypes and coronary atherosclerosis in SLE: a case–control study
por: Samuelsson, Isak, et al.
Publicado: (2021)

Evaluation of the Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in SLE
por: Raghunath, Sudha, et al.
Publicado: (2021)

Characteristics of cardiovascular autonomic dysfunction and association with quality of life in patients with systemic lupus erythematosus
por: Zinglersen, Amanda Hempel, et al.
Publicado: (2021)

Major infections in newly diagnosed systemic lupus erythematosus: an inception cohort study
por: Wang, Haiting, et al.
Publicado: (2022)

Impact of severe infections in SLE: an observational study from the Spanish national registry
por: Moreno-Torres, Victor, et al.
Publicado: (2022)

Clinical associations of cognitive dysfunction in systemic lupus erythematosus
por: Raghunath, Sudha, et al.
Publicado: (2023)

Generic and disease-adapted cardiovascular risk scores as predictors of atherosclerosis progression in SLE
por: Panopoulos, Stylianos, et al.
Publicado: (2023)

Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosus
por: Bruera, Sebastian, et al.
Publicado: (2023)

Relationship between retinal microvascular impairment and subclinical atherosclerosis in SLE
por: Ferrigno, Sara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pnov57t5u8ivjst8als0risvvd